Skip to main content
. 2017 Sep 28;58(6):1128–1134. doi: 10.3349/ymj.2017.58.6.1128

Table 5. Comparison of Subsequent Thrombotic Events According to Antiplatelet Therapy/Anticoagulation among Patients with Definite APS.

Antiplatelet agent (n = 22) Anticoagulation (n = 24) Total (n = 46) Unadjusted
HR (95% CI) p value
Recurrence of any thrombotic events 6 (27.3%) 8 (33.3%) 14 (30.4%) 0.992 (0.341–2.891) 0.989

APS, antiphospholipid syndrome; HR, hazard ratio; CI, confidence interval.